Genetic Variation in the SLC8A1 Calcium Signaling Pathway Is Associated with Susceptibility to Kawasaki Disease and Coronary Artery Abnormalities

Circulation: Cardiovascular Genetics

Volumn 9, Issue 6, 2016, Pages 559-568

  Shimizu, Chisato ^a   Eleftherohorinou, Hariklia ^d   Wright, Victoria J ^d   Kim, Jihoon ^b   Alphonse, Martin P ^e   Perry, James C ^c   Cimaz, Rolando ^f   Burgner, David ^g   Dahdah, Nagib ^h   Hoang, Long T ⁱ   Khor, Chiea Chuen ⁱ   Salgado, Andrea ^a   Tremoulet, Adriana H ^c   Davila, Sonia ⁱ   Kuijpers, Taco W ⁱ   Hibberd, Martin L ^i,j   Johnson, Todd A ^k   Takahashi, Atsushi ^k,l   Tsunoda, Tatsuhiko ^k,m   Kubo, Michiaki ^k   Tanaka, Toshihiro ^k,m   Onouchi, Yoshihiro ^k,n   Yeung, Rae S M ^e   Coin, Lachlan J M ^o   Levin, Michael ^d   Burns, Jane C ^a,c   more..

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h UNIVERSITY OF MONTREAL   (Canada)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k Institute of Physical and Chemical Research   (Japan)

^l NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^m TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁿ CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o UNIVERSITY OF QUEENSLAND   (Australia)

more..

Author keywords

aneurysm; calcium channel; coronary artery; Kawasaki disease; quantitative trait loci; sodium calcium exchanger

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; RYANODINE RECEPTOR 2; SODIUM CALCIUM EXCHANGE PROTEIN; SOLUTE CARRIER FAMILY 8 MEMBER 1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL BETA2; SODIUM-CALCIUM EXCHANGER 1;

ALLELE; ARTICLE; B LYMPHOCYTE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY ANOMALY; ELECTROCARDIOGRAM; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATORY CELL; JAPANESE (PEOPLE); LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; BIOLOGY; CORONARY ANEURYSM; FEMALE; GENE FREQUENCY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; INFANT; MALE; META ANALYSIS; METABOLISM; PHENOTYPE; PRESCHOOL CHILD; QUANTITATIVE TRAIT LOCUS; RISK FACTOR; TRANSFORMED CELL LINE;

B-LYMPHOCYTES; CALCIUM SIGNALING; CELL LINE, TRANSFORMED; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; CORONARY ANEURYSM; DATABASES, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HOMOZYGOTE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS; SODIUM-CALCIUM EXCHANGER;

EID: 85007199270     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.116.001533     Document Type: Article

References (36)

1. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153:117-121. doi: 10.1016/j.jpeds.2007.12.021.
2. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79-85.
3. Onouchi Y. Genetics of Kawasaki disease: what we know and don't know. Circ J. 2012;76:1581-1586.
4. Eleftherohorinou H, Hoggart CJ, Wright VJ, Levin M, Coin LJ. Pathwaydriven gene stability selection of two rheumatoid arthritis GWAS identifies and validates new susceptibility genes in receptor mediated signalling pathways. Hum Mol Genet. 2011;20:3494-3506. doi: 10.1093/hmg/ddr248.
5. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al; Hong Kong-Shanghai Kawasaki Disease Genetics Consortium; Korean Kawasaki Disease Genetics Consortium; Taiwan Kawasaki Disease Genetics Consortium; International Kawasaki Disease Genetics Consortium; US Kawasaki Disease Genetics Consortium; Blue Mountains Eye Study. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43:1241-1246. doi: 10.1038/ng.981.
6. Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, et al. Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet. 2011;4:16-25. doi: 10.1161/CIRCGENETICS.110.940858.
7. O'Connell J, Gurdasani D, Delaneau O, Pirastu N, Ulivi S, Cocca M, et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 2014;10:e1004234. doi: 10.1371/journal.pgen.1004234.
8. Eleftherohorinou H, Wright V, Hoggart C, Hartikainen AL, Jarvelin MR, Balding D, et al. Pathway analysis of GWAS provides new insights into genetic susceptibility to 3 inflammatory diseases. PLoS One. 2009;4:e8068. doi: 10.1371/journal.pone.0008068.
9. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, et al; Japan Kawasaki Disease Genome Consortium; US Kawasaki Disease Genetics Consortium. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012;44:517-521. doi: 10.1038/ng.2220.
10. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol. 2013;44:189-198. doi: 10.1016/j.humpath.2012.05.004.
11. Hoang LT, Shimizu C, Ling L, Naim AN, Khor CC, Tremoulet AH, et al. Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med. 2014;6:541. doi: 10.1186/s13073-014-0102-6.
12. Kim JW, Hong KW, Go MJ, Kim SS, Tabara Y, Kita Y, et al. A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval. Am J Hum Genet. 2012;91:180-184. doi: 10.1016/j. ajhg.2012.05.019.
13. Romero JR, Rivera A, Lança V, Bicho MD, Conlin PR, Ricupero DA. Na+/Ca2+ exchanger activity modulates connective tissue growth factor mRNA expression in transforming growth factor beta1-and Des-Arg10-kallidin-stimulated myofibroblasts. J Biol Chem. 2005;280:14378-14384. doi: 10.1074/jbc.M410052200.
14. Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, et al. Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One. 2012;7:e38998. doi: 10.1371/journal.pone.0038998.
15. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47:305-310. doi: 10.1111/j.1442-200x.2005.02049.x.
16. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 2003;4:517-529. doi: 10.1038/nrm1155.
17. Onouchi Y, Fukazawa R, Yamamura K, Suzuki H, Kakimoto N, Suenaga T, et al. Variations in ORAI1 gene associated with Kawasaki Disease. PLoS One. 2016;11:e0145486. doi: 10.1371/journal.pone.0145486.
18. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40:35-42. doi: 10.1038/ng.2007.59.
19. Quednau BD, Nicoll DA, Philipson KD. Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am J Physiol. 1997;272(4 pt 1):C1250-C1261.
20. Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, et al. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013;168:3825-3828. doi: 10.1016/j. ijcard.2013.06.027.
21. Zhang YG, Hu YC, Mao YY, Wei RH, Bao SL, Wu LB, et al. Transforming growth factor-β1 involved in urotensin II-induced phenotypic differentiation of adventitial fibroblasts from rat aorta. Chin Med J (Engl). 2010;123:3634-3639.
22. Zhang YG, Li J, Li YG, Wei RH. Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta. J Hypertens. 2008;26:1119-1126. doi: 10.1097/HJH.0b013e3282fa1412.
23. Tran L, Kompa AR, Kemp W, Phrommintikul A, Wang BH, Krum H. Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats. Am J Physiol Heart Circ Physiol. 2010;298:H608-H613. doi: 10.1152/ajpheart.00942.2009.
24. Segain JP, Rolli-Derkinderen M, Gervois N, Raingeard de la Blétière D, Loirand G, Pacaud P. Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes. J Immunol. 2007;179:901-909.
25. Staiano RI, Granata F, Secondo A, Petraroli A, Loffredo S, Frattini A, et al. Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes. Eur J Immunol. 2009;39:1405-1418. doi: 10.1002/eji.200838792.
26. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol. 1990;56:29-36.
27. Zheng YM, Wang YX. Sodium-calcium exchanger in pulmonary artery smooth muscle cells. Ann N Y Acad Sci. 2007;1099:427-435. doi: 10.1196/annals.1387.017.
28. Kemény LV, Schnúr A, Czepán M, Rakonczay Z Jr, Gál E, Lonovics J, et al. Na+/Ca2+ exchangers regulate the migration and proliferation of human gastric myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2013;305:G552-G563. doi: 10.1152/ajpgi.00394.2012.
29. Sakamoto K, Owada Y, Shikama Y, Wada I, Waguri S, Iwamoto T, et al. Involvement of Na+/Ca2+ exchanger in migration and contraction of rat cultured tendon fibroblasts. J Physiol. 2009;587(pt 22):5345-5359. doi: 10.1113/jphysiol.2009.172080.
30. Rahamimoff H, Elbaz B, Alperovich A, Kimchi-Sarfaty C, Gottesman MM, Lichtenstein Y, et al. Cyclosporin A-dependent downregulation of the Na+/Ca2+ exchanger expression. Ann N Y Acad Sci. 2007;1099:204-214. doi: 10.1196/annals.1387.046.
31. Maeda S, Matsuoka I, Iwamoto T, Kurose H, Kimura J. Down-regulation of Na+/Ca2+ exchanger by fluvastatin in rat cardiomyoblast H9c2 cells: involvement of RhoB in Na+/Ca2+ exchanger mRNA stability. Mol Pharmacol. 2005;68:414-420. doi: 10.1124/mol.104.000786.
32. Maeda S, Sakamoto K, Matsuoka I, Iwamoto T, Kimura J. Lysophosphatidylcholine increases Na+/Ca2+ exchanger expression via RhoB-geranylgeranylation in H9c2 cells. J Pharmacol Sci. 2009;109:565-572.
33. Kudryavtseva O, Aalkjaer C, Matchkov VV. Vascular smooth muscle cell phenotype is defined by Ca2+-dependent transcription factors. FEBS J. 2013;280:5488-5499. doi: 10.1111/febs.12414.
34. Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, et al. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30:871-876. doi: 10.1097/INF.0b013e318220c3cf.
35. Tremoulet AH. The role of statins in inflammatory vasculitides. Autoimmunity. 2015;48:177-180. doi: 10.3109/08916934.2015.1027818.
36. Aoyagi R, Hamada H, Sato Y, Suzuki H, Onouchi Y, Ebata R, et al; KAICA Trial Investigators. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial). BMJ Open. 2015;5:e009562. doi: 10.1136/bmjopen-2015-009562.